Stage IV Colorectal Cancer Clinical Trial
Official title:
Phase I/II Study of Intravenous Ascorbic Acid in Combination With Irinotecan Versus Irinotecan Alone for Advanced Colorectal Cancer
This protocol is a phase I/II, study of ascorbic acid (AA) infusions combined with treatment with irinotecan versus treatment with irinotecan alone in patients with recurrent or advanced colorectal cancer who have failed at least one treatment regimen with a 5-FU based therapy. This study will be conducted as an amendment to Investigational New Drug # 77486.
Phase I: To assess whether or not (IV) Ascorbic Acid (AA) with irinotecan therapy is
relatively safe and well-tolerated. This aim will be assessed by enrolling a minimum of 6
subjects meeting inclusion criteria, using a modified 3+3 design. Safety will be assessed
with the following: toxicity graded by the NCI CTC, urinalysis pre- and post-infusion, basic
metabolic panel, and CBC. From our experience and in the experience of our study
collaborators, we hypothesize that the combination of IV AA with irinotecan will not be
associated with adverse events.
Phase II: To utilize CT or PET/CT (when available) scans to evaluate disease progression to
assess overall tumor response rate (complete and partial response) in subjects with advanced
or recurrent colorectal cancer treated with the combination of ascorbic acid and irinotecan
versus irinotecan alone.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01704703 -
Study of FOLFIRI + Panitumumab Using Ultra-selection Technology of Patients With Stage IV Colorectal Cancer Refractory to Irinotecan Without Any Mutation on KRAS, PIK3Ca, BRAF and NRAS Genes Detected With Highly Sensitive Techniques
|
Phase 2 | |
Terminated |
NCT02960282 -
Gut Microbiome in Fecal Samples From Patients With Metastatic Cancer Undergoing Chemotherapy or Immunotherapy
|
||
Completed |
NCT01998152 -
Individualized Nutritional Counselling During Chemotherapy for Colorectal Cancer (COLONUT)
|
N/A | |
Not yet recruiting |
NCT06287723 -
French Assessment of MRD by Liquid Biopsies in Colorectal With Liver Metastasis Patients (FRENCH.MRD.CRLM)
|
||
Completed |
NCT03005002 -
Durvalumab and Tremelimumab in Treating Patients With Microsatellite Stable Metastatic Colorectal Cancer to the Liver
|
Phase 1 | |
Completed |
NCT03095781 -
Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer
|
Phase 1 | |
Terminated |
NCT03111823 -
Exercise Program During Chemotherapy in Metastatic Colorectal Cancer
|
N/A | |
Active, not recruiting |
NCT04267575 -
Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites
|
N/A | |
Recruiting |
NCT03368963 -
TAS102 in Combination With NAL-IRI in Advanced GI Cancers
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04670445 -
Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer
|
N/A | |
Active, not recruiting |
NCT01271582 -
Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients
|
Phase 4 | |
Active, not recruiting |
NCT03800602 -
Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal Cancer
|
Phase 2 | |
Recruiting |
NCT05631574 -
Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer
|
Phase 1 | |
Completed |
NCT03112668 -
Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners
|
N/A | |
Recruiting |
NCT02919644 -
Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer.
|
Phase 2 | |
Completed |
NCT03373188 -
VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer
|
Phase 1 | |
Terminated |
NCT04044430 -
Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer
|
Phase 1 | |
Completed |
NCT05025748 -
Ask Questions (ASQ):Implementation of a Communication Intervention
|
N/A | |
Completed |
NCT01722903 -
Detection of CTCs in Patients Undergoing Surgery for Stage IV Colorectal Cancer
|
N/A | |
Completed |
NCT02809716 -
High Definition Single Cell Analysis in Colorectal Cancer
|